| EIF2S1 |
EIF2S1, EIF2A: Eukaryotic translation initiation factor 2 subunit 1 |
G3BP |
G3BP1, G3BP: Ras GTPase-activating protein-binding protein 1 |
0.42 |
Evidence |
|
| ITGB2 |
ITGB2, CD18, MFI7: Integrin beta-2 precursor |
RPS6KA1 |
RPS6KA1, RSK1: Ribosomal protein S6 kinase alpha-1 |
0.42 |
Evidence |
|
| ITGB2 |
ITGB2, CD18, MFI7: Integrin beta-2 precursor |
HCLS1 |
HCLS1, HS1: Hematopoietic lineage cell-specific protein |
0.42 |
Evidence |
|
| TGFB1 |
TGFB1, TGFB: Transforming growth factor beta-1 precursor |
ITGB2 |
ITGB2, CD18, MFI7: Integrin beta-2 precursor |
0.42 |
Evidence |
|
| EIF3S4 |
EIF3S4: Eukaryotic translation initiation factor 3 subunit 4 |
EHD1 |
EHD1, PAST, CDABP0131, PAST1: EH domain-containing protein 1 |
0.42 |
Evidence |
|
| MYCBP2 |
MYCBP2, KIAA0916, PAM: Probable E3 ubiquitin-protein ligase MYCBP2 |
TAOK3 |
TAOK3, DPK, JIK, KDS, MAP3K18: Serine/threonine-protein kinase TAO3 |
0.42 |
Evidence |
|
| EIF5B |
EIF5B, IF2, KIAA0741: Eukaryotic translation initiation factor 5B |
SSB |
SSB: Lupus La protein |
0.42 |
Evidence |
|
| SYNCRIP |
SYNCRIP, HNRPQ, NSAP1: Heterogeneous nuclear ribonucleoprotein Q |
EPRS |
EPRS, GLNS, PARS, QARS, QPRS: Bifunctional aminoacyl-tRNA synthetase [Includes: |
0.42 |
Evidence |
|
| ARPC1B |
ARC41, ARPC1B: Actin-related protein 2/3 complex subunit 1B |
RGS19 |
RGS19, GAIP, GNAI3IP: Regulator of G-protein signaling 19 |
0.42 |
Evidence |
|
| XPO1 |
XPO1, CRM1: Exportin-1 |
ANP32B |
ANP32B, APRIL, PHAPI2: Acidic leucine-rich nuclear phosphoprotein 32 family memb |
0.42 |
Evidence |
|
| XPO1 |
XPO1, CRM1: Exportin-1 |
SMC1L1 |
SMC1A, DXS423E, KIAA0178, SB1.8, SMC1, SMC1L1: Structural maintenance of chromos |
0.42 |
Evidence |
|
| XPO1 |
XPO1, CRM1: Exportin-1 |
BTAF1 |
BTAF1, TAF172: TATA-binding protein-associated factor 172 |
0.42 |
Evidence |
|
| OPRM1 |
OPRM1, MOR1: Mu-type opioid receptor |
GNAQ |
GNAQ, GAQ: Guanine nucleotide-binding protein G(q) subunit alpha |
0.417 |
Evidence |
|
| ALK |
ALK: ALK tyrosine kinase receptor precursor |
STAT3 |
|
0.417 |
Evidence |
|
| MCOLN1 |
MCOLN1, ML4, MSTP080: Mucolipin-1 |
TRPV6 |
TRPV6, ECAC2: Transient receptor potential cation channel subfamily V member 6 |
0.417 |
Evidence |
|
| TRPM7 |
TRPM7, CHAK1, LTRPC7: Transient receptor potential cation channel subfamily M me |
RYR1 |
|
0.417 |
Evidence |
|
| TRPM7 |
TRPM7, CHAK1, LTRPC7: Transient receptor potential cation channel subfamily M me |
MCOLN1 |
MCOLN1, ML4, MSTP080: Mucolipin-1 |
0.417 |
Evidence |
|
| KCNB1 |
KCNB1: Potassium voltage-gated channel subfamily B member 1 |
TRPM7 |
TRPM7, CHAK1, LTRPC7: Transient receptor potential cation channel subfamily M me |
0.417 |
Evidence |
|
| GNA13 |
GNA13: Guanine nucleotide-binding protein alpha-13 subunit |
OPRM1 |
OPRM1, MOR1: Mu-type opioid receptor |
0.417 |
Evidence |
|
| KCNH2 |
KCNH2, ERG, ERG1, HERG, HERG1: Potassium voltage-gated channel subfamily H membe |
MCOLN1 |
MCOLN1, ML4, MSTP080: Mucolipin-1 |
0.417 |
Evidence |
|
| KCNH2 |
KCNH2, ERG, ERG1, HERG, HERG1: Potassium voltage-gated channel subfamily H membe |
TRPM7 |
TRPM7, CHAK1, LTRPC7: Transient receptor potential cation channel subfamily M me |
0.417 |
Evidence |
|
| KCNH2 |
KCNH2, ERG, ERG1, HERG, HERG1: Potassium voltage-gated channel subfamily H membe |
KCTD12 |
KCTD12, C13orf2, KIAA1778, PFET1: BTB/POZ domain-containing protein KCTD12 |
0.417 |
Evidence |
|
| ITK |
ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK |
ALK |
ALK: ALK tyrosine kinase receptor precursor |
0.417 |
Evidence |
|
| GNA12 |
GNA12: Guanine nucleotide-binding protein alpha-12 subunit |
OPRM1 |
OPRM1, MOR1: Mu-type opioid receptor |
0.417 |
Evidence |
|
| EFNB1 |
EFNB1, EFL-3, EPLG2, LERK2: Ephrin-B1 precursor |
PHC2 |
PHC2, EDR2, PH2: Polyhomeotic-like protein 2 |
0.417 |
Evidence |
|